Recent antitumor therapy does not increase Omicron COVID-19 severity in cancer patients: a two-center retrospective study in China
Description
CONCLUSION: The severity of COVID-19 caused by the Omicron variant is not exacerbated by recent anticancer therapy in cancer patients. Therefore, anticancer therapy should not be discontinued in such cases, especially those with mild severity.
